Cytotoxicity and Preliminary Analysis of the Pro-apoptotic and Cell Cycle Arrest Effects of Lantana ukambensis Against Colorectal Cancer Cells
Wamtinga Richard Sawadogo1,2,3*, Yun Luo1,2,4, Bethany Elkington5, Tong-Chuan He6, Chong-Zhi Wang1,2, Chun-Su Yuan1,2
1Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, 60637, USA
2Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, 60637, USA
3Institut de Recherche en Sciences de la Santé (IRSS/CNRST), 03 BP 7192, Ouagadougou 03, Burkina Faso
4Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China
5College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, 60612, USA
6Department of Orthopedic Surgery and Rehabilitation Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, 60637, USA
*Corresponding Author: Wamtinga Richard Sawadogo, PhD, Institut de Recherche en Sciences de la Santé (IRSS/CNRST), 03 BP 7192, Ouagadougou 03, Burkina Faso
Received: 23 July 2020; Accepted: 04 August 2020; Published: 07 August 2020
Wamtinga Richard Sawadogo, Yun Luo, Bethany Elkington, Tong-Chuan He, Chong-Zhi Wang, Chun-Su Yuan. Cytotoxicity and Preliminary Analysis of the Pro-apoptotic and Cell Cycle Arrest Effects of Lantana ukambensis Against Colorectal Cancer Cells. International Journal of Applied Biology and Pharmaceutical Technology 11 (2020): 170-187.View / Download Pdf Share at Facebook
Lantana ukambensis (Vatke) Verdc. (Verbenaceae) is a seasonal herb widely spread in the West African region. The whole plant is used for the treatment of wounds, infections, and inflammatory pathologies. The purpose of this research is to evaluate the cytotoxicity and to analyze the probable pro-apototic, and cell cycle arrest effects of L. ukambensis methylene chloride extract and its fractions against HCT-116 and HT-29 colorectal cancer cells using preliminary tests in order to highlight the interest of this plant in the search of new anticancer molecules. The dried powder of the whole plant was extracted by methylene chloride maceration for 24 hours and the extract was divided into five fractions. The cytotoxicity of the crude extract and fractions were evaluated by the MTS assay. The most active fractions were subjected to some preliminary assays including crystal violet, Hoechst staining, cell cycle arrest, and annexin V/PI assays on the cancer cells to highlight the probable mechanism of action of these fractions. The methylene chloride, ethyl acetate, and 1-butanol fractions of L. ukambensis crude extract demonstrated significant antiproliferative effects on HCT-116 and HT-29 cell growth with IC50 values ranging between 2 to 15 µg/mL. 1-butanol and ethyl acetate fractions decreased the G1 phase by 20.53% and 28.47% and increased the G2/M by 23.47% and 25.90% respectively on HCT-116. Moreover, 1-butanol fraction increased the cumulative value of apoptotic cells by 49.77% on HCT-116 and ethyl acetate fraction increased this value by 53.37% at 15 µg/mL after 48 hours of exposure. The outcome of this study suggests the potential of 1-butanol and ethyl acetate fractions for the isolation of anticancer molecules against colorectal cancer.
Medicinal plants; Cancer; Cytotoxicity; Apoptosis; Cell cycle arrest
Medicinal plants articles, Cancer articles, Cytotoxicity articles, Apoptosis articles, Cell cycle arrest articles
Lantana ukambensis (Vatke) Verdc. (Verbenaceae) is a seasonal herb widely spread in the West African region, especially in areas with a tropical climate . Its red fruits are widely eaten by children in the countryside whilst the whole plant is used in traditional medicine for the management of many diseases. In Burkina Faso’s folk medicine, L. ukambensis whole plant is used for the treatment of wounds, infections, and inflammatory pathologies . Our previous studies demonstrated the antioxidant, antiproliferative, and antileishmanial activities of L. ukambensis as a scientific base of its traditional uses [1,2,3,5]. The World Health Organization (WHO) estimates that more than 80% of the African population use traditional medicine for their primary health care. These traditional uses are justified by cultural and economic reasons [4,5]. Plants are the most important component of this traditional medicine and constitute an important source of therapeutic compounds to improve the population’s quality of health [4,6,7,8].
Among the most dreaded pathologies in the world, cancer is one of the most difficult to overcome due to the multiple types, forms, and various causes, as well as frequent chemo-resistance. Cancer is considered to be the second leading cause of death in the world with an estimated number of 18.1 million new cases and 9.6 million deaths in 2018 . Unfortunately, the number of new cancer cases per year is expected to rise to 23.6 million by 2030. Among the most common cancers, the WHO estimates that colon cancer occupies the third position after lung and breast cancers, with 1.80 million cases reported in 2018 [9,10].
Conventional medicine, as well as traditional medicine, offer treatments for cancer patients. However these therapies are not always safe. Indeed, conventional chemotherapeutic drugs, especially from synthetic origin, target the receptor of both normal and cancer cells due to non-selective toxicity and may induce severe side effects and high toxicity leading to a deterioration in the quality of life of patients . On the other side, traditional healers often have a different view about the physiopathology of cancer, the doses of administration, and the level of toxicity of their plant extracts, which can lead to long-term toxicity including liver toxicity, genotoxicity, kidney toxicity, and gastro-intestinal disturbances [12,13].
For all of these reasons, the research of new anticancer drugs is more and more focused on natural compounds, especially from medicinal plants. In fact, it’s estimated that at least 60% of new anticancer molecules have been derived from natural compounds . Our previous studies revealed that L. ukambensis is a potential source of new anticancer molecules. Indeed, we demonstrated the cytotoxic effect of the methylene chloride extract of this plant against cancer cell lines including KB, K562, U937, Jurkat and Raji with less toxicity on healthy peripheral blood mononuclear cells (PBMCs) . In addition, the phytochemical screening showed the presence of saponins, flavonoids, tannins, triterpenoids, and steroids in the extract of L. ukambensis. These compounds are well-known for their anticancer properties. Recently, we isolated one compound, 5-hydroxy-6,7,3’,4’,5’-pentamethoxyflavone, which showed significant antiproliferative and pro-apoptotic effect against U937 cells .
The purpose of this research is to evaluate the cytotoxicity and to analyze the probable pro-apototic, and cell cycle arrest effects of L. ukambensis methylene chloride extract and its fractions against HCT-116 and HT-29 colorectal cancer cells using preliminary tests in order to highlight the interest of this plant in the search of new anticancer molecules.
Materials and Methods
The solvents used in this study were obtained from fisher Scientific (Norcross, GA) with HPLC grade; cell culture medium (McCoy’s 5A, Leibovitz’s L-15) and serum (FBS) from Mediatech, Inc. (Herndon, VA); antibiotics (penicillin and streptomycin) from Sigma-Aldrich (St. Louis, MO, USA); Milli-Q deionized water (18 MΩ-cm) system from Millipore (Milford, MA, USA); The reagents (MTS assay kit, CellTiter for Cell Proliferation Assay Promega (Madison, WI, USA); fiTC-Annexin V kit from BD Biosciences (Rockville, MD, USA); PI/RNase staining buffer from BD Biosciences Pharmingen (San Diego, CA, USA); cell culture plastic materials from Falcon Labware (Franklin Lakes, NJ, USA).
The whole plant of L. ukambensis (Vatke) Verdc. (Verbenaceae) was collected by Sawadogo WR in August, 2018 by Bobo Dioulasso (Burkina Faso) with the following GPS position: Latitude (dd) of 17.22320 and Longitude (dd) of -7.25314. The plant was previously collected in the same area and identified in 2010 by Professor Millogo Jeanne at the Laboratory of Ecology, University Joseph Ki-Zerbo of Ouagadougou, Burkina Faso. The identification was confirmed by Professor Amadé Ouedraogo, botanist at the Laboratory of Ecology, University Joseph Ki-Zerbo of Ouagadougou. A voucher specimen was deposited at the herbarium of the National center for scientific research and technology of Burkina Faso under the specimen number LU-003.
Extraction and Fractionation
An amount of 100g of L. ukambensis powder was submitted to maceration in methylene chloride (500mL) with stirring during 24 hours. After filtration, the extract was evaporated and lyophilized to obtain dried extract (7.5g). An amount of 2g of the crude extract was dissolved in 10 mL of DMSO plus 90 mL of distilled water for the liquid-liquid fractionation with the following solvents: Petroleum ether (PE), methylene chloride (MC), ethyl acetate (EA), and 1-buthanol (1B). The five fractions were dried through evaporation and lyophilization and the dried extracts was used for biological assays.
Colorectal cancer cells (HCT-116, HT-29) from the American Type Tissue Collection (Rockville, MD, USA) were cultured in McCoy's 5A, added by 10% FBS, penicillin (100IU/ml), and streptomycin (100µg/ml). HCT-116 and HT-29 were incubated at 37&de;C in 5% CO2 environment and sub-cultured every two days according to the protocol described by Wang et al, 2006 . Briefly, when the cells covered 90% of the flask’s surface area with free of contamination, they are collected by adding 1mL of trypsin and 2mL of collected cells are re-suspended into a new flask containing 8mL of culture medium.
Cell Proliferation Analysis
The MTS assay was used to analyze the effect of L. ukambensis on colorectal cancer cells proliferation as described by Wang et al . The plant extract and fractions were dissolved in DMSO and stored at 4°C before use. HCT-116 and HT-29 cells were placed in a 96-well plate and incubated at 37°C plus 5% CO2. After 24 hours on incubation, the medium in each well was replaced by 200 µL of new culture medium and the tested samples at different concentrations were added to the wells. The crude extract was tested at concentrations ranged from 10 to 300µg/mL after 48 hours in order to verify the level of its cytotoxicity against colorectal cancer cells. The fractions of this crude extract were tested at 5 and 50µg/mL after 48 hours of exposure to select the most cytotoxic fractions. After this selection, the antiproliferative effect was performed at 1, 2, 4, 5, 8, 10µg/mL after 24, 48 and 72 hours of exposure in order to determine the IC50 values of these fractions. Control wells received culture medium plus the same quantity of DMSO without drugs. In order to avoid false results, the final concentration of DMSO in tested groups did not exceed 1%. Wells containing medium but no cells are considered as blank. After 48 hours of exposure, the medium in each well was replaced by 100µL of fresh medium plus 20µL of CellTiter 96 solution. This reagent in contact with viable cells is bio-reduced by dehydrogenase enzymes into a formazan product. The number of living cells is determined by measuring the quantity of formazan product which correspond to the amount of absorbance at 490nm. After 2 hours of incubation; 60µL of medium from each well was transferred to an ELISA 96-well plate, and the absorbance of the formazan product at 490 nm was measured. Results were expressed as percent of control (DMSO vehicle set at 100%) from three independents assays.
Crystal Violet Staining Assay
The crystal violet staining assay was performed as described by Wan et al, 2018 . Briefly, the cancer cells were placed in 24-well plates at 100 cells/well. After 24 h of incubation, the medium was removed and replaced by fresh culture medium plus different concentrations of the most cytotoxic fractions of L. ukambensis. The tested concentrations (5, 10 and 15µg/mL) were chosen according to the IC50 values of the cytotoxic fractions. After 48 hours of exposure, the cells were washed and stained with 0.2% crystal violet in 10% phosphate-buffered formaldehyde for 2 min. Cells were then washed with PBS and the adherent cells at the bottom of each well were photographed under a microscope in order to analyze morphological changes in the cytoplasmic vacuoles of each cell.
Preliminary Cell Cycle Analysis
The effect of the active fractions of L. ukambensis on the cell cycle phases was analyzed, especially on the G1, S, and G2/M phases, as described by Yao et al, 2018 . HCT-116 and HT-29 cells were incubated in 24-well plates for 24 hours. The cell culture medium was removed and replaced by fresh medium plus different concentrations of plant fractions and incubated for 48 hours. These concentrations (5, 10 and 15µg/mL) were chosen according to the IC50 values of the fractions. The cells were then collected by centrifugation (2000 rpm / 5 minutes) and fixed by 100% ethanol at 4°C for 2 hours. After treatment with 0.25% Triton X-100 for 5 min on an ice bath, each cell line was re-suspended in 300µl of PBS, 40µg/ml propidium iodide (PI) and 0.1mg/ml RNase and incubated in the dark at room temperature for 20 min. Cell cycle analysis was performed using a LSRII flow cytometer 585 nm (BD Biosciences, Franklin Lakes, NJ) and FlowJo 10.1.0 software (Tree Star, Ashland, OR, USA). In order to increase the level of accuracy, at least 20,000 cells were counted for each measurement.
Preliminary Pro-apoptosis Analysis
Two methods were performed for the preliminary analysis of the pro-apoptotic effect of L. ukambensis extract and fractions: Hoechst 33258 staining and Annexin V/ Propidium Iodide assays as described in our previous works [1,14].
Hoechst 33258 Staining Assay
The Hoechst 33258 staining assay was performed as previously described by Sawadogo et al., 2015  in order to analyze, by fluorescence microscope at 365 nm, the nuclear fragmentation in cells treated by cytotoxic agent. Briefly, the colorectal cancer cells were seeded in a 24-well plate at 100,000 cells/well and treated with different concentrations of the plant extracts for 48 hours. These concentrations (5, 10 and 15µg/mL) were chosen according to the IC50 values of the fractions. In each well, 1mL of trypsin was added to remove the cells for centrifugation at 2000 rpm / 5 min. Then the cells were collected and stained with 0.01mg/mL Hoechst 33258, 33mg/mL formalhehyde, and 5mg/mL NP-40 in PBS for 10 min in the dark. finally, the nuclear fragmentation in treated cells was observed and photographed using fluorescence microscopy.
Annexin V/ Propidium Iodide staining (PI) assays
Annexin V is a Ca2+-dependent phospholipid-binding protein that binds strongly to phosphatidylserine residues translocated to the outside of the apoptotic cells at the early stage of apoptosis. Then, cell apoptosis can be assayed by flow cytometry after staining with annexin V. Briefly, cells were seeded in 24-well plates at the concentration of 200,000 cells/well for 48 hours. The medium was removed and replaced by fresh one and the plant extracts were added in the treated wells at 5, 10 and 15µg/mL. These concentrations were chosen according to the IC50 values of the fractions. After 48 hours of exposure, cells floating in the medium were harvested using trypsin and centrifugation of 5 min at 600g. The collected cells were stained with annexin-V fiTC and propidium iodide (PI), according to the manufacturer’s instructions. Cells in medium culture without extracts were used as a control for double staining. Stained samples were analyzed by FACScan flow cytometer (Becton Dickinson, Mountain View, CA) and Flow Jo software (Tree Star, Ashland, OR). In order to increase the level of accuracy, at least 20,000 cells were counted for each measurement.
Data are presented as the mean of at least three independent assays (M±SD). A two-way ANOVA of multiple comparisons from GraphPad Prism 6 was employed to determine whether the results had statistical significance. In some cases, the student’s t-test was used for comparing two groups. The difference is significance at p<0.05. In each figure, one star (*) corresponds to the p<0.05, 2 stars (**) for p<0.01, 3 stars (***) for p<0.001, and 4 stars (****) for p<0.0001.
The crude methylene chloride extract of L. ukambensis showed significant cytotoxic effect against both colorectal cancer cell lines after 48 hours of treatment at 20µg/mL for HCT-116 and 80µg/mL for HT-29. (figure 1).
figure 1: Cytotoxic effect of the crude methylene chloride extract of L. ukambensis on HCT-116 and HT-29 at concentrations ranged from 10 to 300µg/mL after 48 hours of exposure. The results are the mean ± SD of three independent assays. The level of statistical significance was set at p<0.05. In each figure, one star (*) corresponds to the p<0.05, 2 stars (**) for p<0.01, 3 stars (***) for p<0.001, and 4 stars (****) for p<0.0001.
The five fractions from L. ukambensis crude extract demonstrated significant cytotoxicity against both cell lines at 50µg/mL after 48 hours of exposure (figure 2). At 5µg/mL, the most cytotoxic fractions are those from methylene chloride, ethyl acetate, and 1-butanol (figure 2). These most cytotoxic fractions were tested at different concentrations and time points in order to determine their IC50 values. All of these fractions showed significant cytotoxic effect on HCT-116 and HT-29 cells (figure 3) in a dose dependent manner.
The concentrations of L. ukambensis crude extract and its most cytotoxic fractions, which inhibited 50% of cancer cells proliferation (IC50), are indicated in table 1. Among them, the ethyl acetate fraction is found to be the most cytotoxic. Indeed, this fraction demonstrated ten times more cytotoxicity on HCT-116 and twenty times on the HT-29 cells, when compared to the crude extract.
figure 2: Cytotoxic effect of five fractions from crude methylene chloride extract of L. ukambensis on HCT-116 and HT-29 at 5 and 50µg/mL after 48 hours of exposure. PE=Petroleum ether, MC= Methylene choride, EA= Ethyl acetate, 1B= 1-Butanol, H2O= Water, DMSO=Dimethylsulfoxyde. The results are the mean ± SD of three independent assays. The level of statistical significance was set at p<0.05. In each figure, one star (*) corresponds to the p<0.05, 2 stars (**) for p<0.01, 3 stars (***) for p<0.001, and 4 stars (****) for p<0.0001.
figure 3: Cytotoxic effect of active fractions (MC, EA and 1B) from L. ukambensis on HCT-116 and HT-29 at 1, 2, 4, 5, 8 and 10µg/mL after 24, 48, and 72 hours of exposure. The results are the mean ± SD of three independent assays. The level of statistical significance was set at p<0.05. In each figure, one star (*) corresponds to the p<0.05, 2 stars (**) for p<0.01, 3 stars (***) for p<0.001, and 4 stars (****) for p<0.0001.
Crystal violet staining
The crystal violet method allows cell morphology observation by microscope, when treated with L. ukambensis fractions. The results showed that at 48 hours of exposure, the three fractions (methylene chloride, 1-butanol, and ethyl acetate) induced damages on both cancer cells morphology (HCT-116 and HT-29) until cell death (figures 4) at 15µg/mL. Results were confirmed by three independent analyses. The effect of these fractions is in a dose dependent manner.
Preliminary cell cycle analysis
Cell cycle analysis is performed to assess the impact of the cytotoxic fractions on the different phases of the cell cycle, including G1, S, and G2/M. The results were confirmed by three independent analyses (figure 5). At 15µg/mL, 1-butanol fraction induced a decrease in G1 phase of 20.53% and an increase of 23.47% in G2/M phases on HCT-116 after 48 hours of exposure, whilst the inverse effects were observed against HT-29; where the G1 phase was increased by 24.6% and G2/M decreased by 2.90%. In the same condition, the ethyl acetate fraction decreased the G1 phase by 28.47% and increased the G2/M by 25.90% on HCT-116 whilst on HT-29 the G1 phase was lightly increased by 2.5% and the G2/M decreased by 10.26% (figure 6). In both cell lines, the fractions have no significant effect on the S phase. The methylene chloride fraction did not show significant effect on the cycle cell of either colorectal cancer cells.
Preliminary Pro-apoptosis Analysis
The pro-apoptotic effect of the most active fractions was evaluated by Hoechst 33258 staining and Annexin V/PI assays. Nucleus fragmentation is the sign of apoptosis when using the Hoechst assay (figure 7). In the Annexin V/PI assay, the apoptotic cells are observed in the right side of the square, including early apoptosis at the bottom, and late apoptosis in the upper, whilst the living cells are at the bottom left side of the square and necrosis in the upper (figure 8). Results of both assays were confirmed by three independent analyses. Significant apoptotic HCT-116 cells were observed at 48 hours in wells treated by 1-butanol and ethyl acetate fractions, whilst at the same conditions, no significant apoptotic effect was induced on HT-29 (figures 7 and 8). In the Annexin V/PI assay, the 1-butanol and ethyl acetate fractions also showed significant apoptotic effect on HCT-116 at 15 µg/mL (figures 8). Indeed, the 1-butanol fraction induced an increase of the cumulative value of early and late apoptosis by 49.77% on HCT-116 and the ethyl acetate increased this value by 53.37% at 15 µg/mL after 48 hours of exposure (figure 9).
Table 1: IC50 values of crude extract and fractions of L. ukambensis on HCT-116 and HT-29 at 48H
23.05 ± 1.56
106.81 ± 4.32
Methylene chloride fraction
5.11 ± 0.52
14.94 ± 2.98
Ethyl acetate fraction
2.41 ± 0.1
5.18 ± 0.31
4.32 ± 0.57
11.64 ± 0.58
figure 6: Quantitative analysis of cell cycle phases S, G1, and G2/M in HCT-116 and HT-29 cells treated with Ethyl acetate, Methylene chloride, and 1-Butanol fractions from Lantana ukambensis at 5, 10, 15µg/mL for 48 hours. The results are the mean ± SD of three independent analysis. The level of statistical significance was set at p<0.05. In each figure, one star (*) corresponds to the p<0.05, 2 stars (**) for p<0.01, 3 stars (***) for p<0.001, and 4 stars (****) for p<0.0001.
figure 8: Apoptosis analysis by cytometry of HCT-116 and HT-29 cells treated with L. ukambensis fractions at 48 hours. The apoptotic cells are observed in the right side of the square, including early apoptosis at the bottom, and late apoptosis in the upper, whilst the living cells are at the bottom left side of the square and necrosis in the upper.
figure 9: Quantitative analysis of early and late apoptosis in HCT-116 and HT-29 treated with Ethyl acetate, Methylene chloride, and 1-Butanol fractions from Lantana ukambensis at 5, 10, and 15µg/mL for 48 hours. The results are the mean ± SD of three independent analysis. The level of statistical significance was set at p<0.05. In each figure, one star (*) corresponds to the p<0.05, 2 stars (**) for p<0.01, 3 stars (***) for p<0.001, and 4 stars (****) for p<0.0001.
The results of this study show that the 1-butanol and ethyl acetate fractions of L. ukambensis are highly cytotoxic to colorectal cancer cells. In general, the HCT-116 cell line is more sensitive to cytotoxic agents compared to HT-29 justifying the fact that the IC50 values of the tested fractions are lowest on HCT-116. Interestingly, our previous research demonstrated that the extracts and fractions from Lantana ukambensis induce low toxicity against healthy cells (Vero, MCR-5 and PBMCs) compared to cancer cell lines (KB, K562, U937, Jurkat and Raji) [1,3]. The ethyl acetate is a polar aprotic solvent whilst the 1-butanol has a role as a protic solvent [17,18]. These type of solvents may contain polar molecules like saponins and polyphenols including tannins, anthocyanins, phenolic acids, flavonoids, and stilbenes [19,20,21]. All these compounds are well known to possess preventive and curative benefits against cancers [22,23,24,25]. Very little research has been published on the anticancer properties of L. ukambensis, and our results constitute the first report on the cytotoxicity, pro-apoptotic, and cell cycle arrest effects of L. ukambensis against colorectal cancer cells HCT-116 and HT-29.
We demonstrated by cytometry that the cytotoxicity of 1-butanol and ethyl acetate fractions of L. ukambensis act probably through cell cycle arrest and apoptosis pathways in colorectal cancer cells HCT-116 and HT-29. Nevertheless, as seen in the MTS assay, the cytotoxicity of these fractions is expressed more than the apoptotic cells revealed by Hoechst and cytometry assays, meaning that there are other mechanisms of action to be explored in our future research. Moreover, we will focus our next step on the isolation of the anticancer molecules in the 1-butanol and ethyl acetate fractions of L. ukambensis.
The pro-apoptotic effect of the most active fractions was confirmed by the significant change induced by these fractions on HCT-116 cell cycle, including a decrease in G1 and an increase in G2/M phases. It is well known that apoptosis and cell proliferation are linked by cell-cycle regulators, and that apoptotic stimuli affect both processes. Indeed some cell-cycle genes including p53, RB, and E2F are implicated in the balance between apoptosis and proliferation. This balance is strictly necessary in order to sustain tissue homeostasis. Moreover, mitosis and apoptosis show very similar morphological features that promotes to a link between apoptosis and cell cycle, even if their DNA structures display some critical differences . The fact that our fractions induce significant modification of HCT-116 cell cycle opens a great perspective to elucidate the impact of the cytotoxic molecules present in these fractions on apoptosis-regulating proteins, as well as cell-cycle genes.
The outcome of this study suggests the interest of L. ukambensis for colorectal cancer management. Indeed the 1-butanol and the ethyl acetate fraction of the crude extract of this plant exhibited significant cytotoxicity against HCT-116 and HT-29 colorectal cancer cells. In addition, these fractions induced significant apoptotic and cell cycle arrest effects on HCT-116 cells. These results constitute a scientific basis for the traditional uses of L. ukambensis and give a great perspective for the isolation and biological investigation of natural anticancer molecules from these plant fractions.
Our work was supported by the U.S. Department of State’s Fulbright Visiting Scholars (PS00267280), the grants of the National Natural Science Foundation of China (81760711, 81460600 and 81603274), the State Scholarship Fund of China Scholarship Council (201808360056), the Natural Science Foundation of Jiangxi Province, China (20171BAB205100 and 20181BAB205080), the 111 Project from the Ministry of Education of China and the State Administration of Foreign Experts Affairs of China (B16046), and U.S. National Institutes of Health grants 5P30DK042086.
The authors report no conflicts of interest in this work.
- Sawadogo WR, Cerella C, Al-Mourabit A, et al. Cytotoxic, antiproliferative and pro-apoptotic effects of 5-hydroxyl-6, 7, 3′, 4′, 5′-pentamethoxyflavone isolated from Lantana ukambensis. Nutrients 7 (2015): 10388-10397.
- Sawadogo WR, Le Douaron G, Maciuk A, et al. In vitro antileishmanial and antitrypanosomal activities of five medicinal plants from Burkina Faso. Parasitology Research 110 (2012): 1779-1783.
- Sawadogo WR, Maciuk A, Banzouzi JT, et al. Mutagenic effect, antioxidant and anticancer activities of six medicinal plants from Burkina Faso. Natural Product Research 26 (2012): 575-57
- Sawadogo WR, Schumacher M, Teiten MH, et al. Traditional West African pharmacopeia, plants and derived compounds for cancer therapy. Biochemical Pharmacology 84 (2012): 1225-12
- Sawadogo WR, Teiten MH, Cerella C, et al. Cytotoxic Effect and NF-κB Inhibition of Fractions from Lantana ukambensis (Verbenacea). Planta Medic 79 (2013):
- Awodele O, Agbaje EO, Ogunkeye FA, et al. Towards integrating traditional medicine (TM) into National Health Care Scheme (NHCS): Assessment of TM practitioners’ disposition in Lagos, Nigeria. Journal of Herbal Medicine 1 (2011): 90-9
- Farnsworth NR, Akerele O, Bingel AS, et al. Medicinal plants in therapy. Bulletin of the world health organization 63 (1985):
- Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PloS One 12 (2017):
- Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20–49 years. JNCI: Journal of the National Cancer Institute 111 (2019): 1279-12
- WHO, Key facts on cancer. Fact sheet (2018).
- Mitra AK, Agrahari V, Mandal A, et al. Novel delivery approaches for cancer therapeutics. Journal of Controlled Release 219 (2015): 248-2
- Chalut DS. Toxicological risks of herbal remedies. Paediatr. Child Health 4 (1999): 536-53
- Zhang, J., Onakpoya, I.J., Posadzki, P., et al. The safety of herbal medicine: from prejudice to evidence. Evid. Based Complement. Alternat. Med (2015):
- Wang CZ, Zhang B, Song WX, et al. Steamed American ginseng berry: ginsenoside analyses and anticancer activities. Journal of Agricultural and Food Chemistry 54 (2006): 9936-99
- Wan JY, Yao H, Zhang CF, et al. Red American ginseng enhances the effect of fluorouracil on human colon cancer cells via both paraptosis and apoptosis pathways. Journal of Applied Biomedicine 16 (2018): 311-31
- Yao H, Wan JY, Zeng J, et al. Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer. Oncology Letters 15 (2018): 8339-83
- National Center for Biotechnology Information (NCBI 2020a). PubChem Database. Ethyl acetate, CID=8857, https://pubchem.ncbi.nlm.nih.gov/compound/Ethyl-acetate (2020)
- National Center for Biotechnology Information (NCBI 2020b). PubChem Database. 1-Butanol, CID=263, https://pubchem.ncbi.nlm.nih.gov/compound/263 (2020)
- Arora S, Itankar P. Extraction, isolation and identification of flavonoid from Chenopodium album aerial parts. Journal of Traditional and Complementary Medicine 8 (2018): 476-4
- Majinda RR. Extraction and isolation of saponins. InNatural Products Isolation (2012): 415-426.
- Sarker SD, Nahar L. Hyphenated techniques and their applications in natural products analysis. InNatural Products Isolation (2012): 301-340.
- Abdal Dayem A, Choi HY, Yang GM, et al. The anti-cancer effect of polyphenols against breast cancer and cancer stem cells: molecular mechanisms. Nutrients 8 (2016):
- Belšcak-Cvitanovic A, Durgo K, Hudek A, et al. Overview of polyphenols and their properties. InPolyphenols: Properties, Recovery, and Applications (2018): 3-44.
- Cvejic JH, Krstonošic MA, Bursac M, et al. Polyphenols. InNutraceutical and Functional Food Components (2017): 203-258.
- Niedzwiecki A, Roomi MW, Kalinovsky T, et al. Anticancer efficacy of polyphenols and their combinations. Nutrients 8 (2016): Pucci B, Kasten M, Giordano A. Cell cycle and apoptosis. Neoplasia 2 (2000): 291-299.